1.
Hussein TA, H. Flaih M. Comparing the Efficacy and Safety of Tumor-Infiltrating Lymphocyte Therapy and Pembrolizumab in Advanced Melanoma: A Randomized Controlled Trial. Acta Med Iran. 2025;63(6):376-385.